Recent News

• 03.10.2025 - NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
• 02.24.2025 - NeoGenomics to Participate in Upcoming Investor Conferences
• 02.18.2025 - 10-K - Annual report pursuant to Section 13 and 15(d)
• 02.18.2025 - NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
• 01.29.2025 - NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
• 01.15.2025 - NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

Recent Filings

• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2025 - EX-99.1 EX-99.1
• 02.18.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.18.2025 - 8-K Current report
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors